New Zealand markets open in 5 hours 5 minutes

AbbVie Inc. (ABBV)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
164.46+1.92 (+1.18%)
As of 12:55PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close162.54
Bid164.09 x 800
Ask164.12 x 800
Day's range163.26 - 164.74
52-week range130.96 - 182.89
Avg. volume5,664,483
Market cap291.201B
Beta (5Y monthly)0.56
PE ratio (TTM)60.69
Earnings dateN/A
Forward dividend & yield6.20 (3.81%)
Ex-dividend date12 Apr 2024
1y target estN/A
  • PR Newswire

    AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA®) for Preventive Treatment of Migraine

    AbbVie (NYSE: ABBV) today announced an interim analysis of an ongoing Phase 3, open-label 156-week extension study evaluating the long-term safety and tolerability of oral atogepant for the prevention of migraine in participants with chronic or episodic migraine. The overall long-term safety results were consistent with the known safety profile of atogepant in chronic and episodic migraine, and no new safety signals were identified. These results also support improvements in key efficacy outcome

  • PR Newswire

    SkinMedica® Empowers Clear Skin Confidence with a New, Modern Approach to Acne

    Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the launch of two new products from SkinMedica® by the makers of BOTOX® Cosmetic. The SkinMedica® Acne Clarifying Treatment and SkinMedica® Pore Purifying Gel Cleanser are breakthroughs in skincare, providing effective and balanced care for people with acne-prone skin. The two products, along with the SkinMedica® Pore Purifying Pro-Infusion Serum, used in-office with DiamondGlow®, complete the protocol, providing acne sufferers

  • PR Newswire

    AbbVie to Host First-Quarter 2024 Earnings Conference Call

    AbbVie (NYSE: ABBV) will announce its first-quarter 2024 financial results on Friday, April 26, 2024, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through AbbVie's Investor Relations website at An archived edition of the session will be available later that day.